tryptophan has been researched along with methyl-thiohydantoin-tryptophan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolomsky, A; Fuchs, D; Graffi, S; Ludwig, H; Pfeifer, S; Sahota, SS; Schreder, M; Zojer, N | 1 |
| Abu Aboud, O; Anderson, K; Berryhill, G; Chen, CH; Graef, A; Hovey, RC; Kim, J; Modiano, JF; Sarver, AL; Stewart, B; Trott, JF; Uzal, F; Weiss, RH; Wettersten, H | 1 |
2 other study(ies) available for tryptophan and methyl-thiohydantoin-tryptophan
| Article | Year |
|---|---|
Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Coculture Techniques; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Interferon-gamma; Mesenchymal Stem Cells; Multiple Myeloma; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet; Thiohydantoins; Tryptophan; Tumor Cells, Cultured; Tumor Microenvironment; Tumor Necrosis Factor-alpha | 2012 |
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Line, Tumor; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Interferon-alpha; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Thiohydantoins; Tryptophan | 2016 |